CVE-2019-10384

Description

Jenkins 2.191 and earlier, LTS 2.176.2 and earlier allowed users to obtain CSRF tokens without an associated web session ID, resulting in CSRF tokens that did not expire and could be used to bypass CSRF protection for the anonymous user.

Category

8.8
CVSS
Severity: High
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.21%
Vendor Advisory redhat.com Vendor Advisory redhat.com Vendor Advisory jenkins.io
Affected: Jenkins project Jenkins
Published at:
Updated at:

References

Link Tags
http://www.openwall.com/lists/oss-security/2019/08/28/4 third party advisory mailing list
https://access.redhat.com/errata/RHSA-2019:2789 third party advisory vendor advisory
https://access.redhat.com/errata/RHSA-2019:3144 third party advisory vendor advisory
https://www.oracle.com/security-alerts/cpuapr2022.html third party advisory patch
https://jenkins.io/security/advisory/2019-08-28/#SECURITY-1491 vendor advisory

Frequently Asked Questions

What is the severity of CVE-2019-10384?
CVE-2019-10384 has been scored as a high severity vulnerability.
How to fix CVE-2019-10384?
To fix CVE-2019-10384, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2019-10384 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2019-10384 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2019-10384?
CVE-2019-10384 affects Jenkins project Jenkins.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.